Biofrontera Inc. Quarterly Debt-to-equity in % from Q2 2022 to Q3 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Biofrontera Inc. quarterly Debt-to-equity history and growth rate from Q2 2022 to Q3 2024.
Biofrontera Inc. Debt-to-equity for the quarter ending September 30, 2024 was 463 %, a 96.5% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	463	+227	+96.5%	Sep 30, 2024
Q2 2024	824	+661	+407%	Jun 30, 2024
Q1 2024	1.48K	+1.33K	+884%	Mar 31, 2024
Q4 2023	374	+216	+137%	Dec 31, 2023
Q3 2023	236	+27.7	+13.3%	Sep 30, 2023
Q2 2023	163	-337	-67.4%	Jun 30, 2023
Q1 2023	150			Mar 31, 2023
Q4 2022	157			Dec 31, 2022
Q3 2022	208			Sep 30, 2022
Q2 2022	499			Jun 30, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.